Condensed Balance Sheets - USD ($)	Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents	$ 6,157,448	$ 12,077,640
Prepaid expenses and other current assets	846,399	807,356
Total current assets	7,003,847	12,884,996
Property and equipment, net	143,145	193,974
Other assets:
Goodwill	7,647,267	7,647,267
In-process research and development	118,600	118,600
Other non-current assets	454,044	620,674
Total assets	15,366,903	21,465,511
Current liabilities:
Accounts payable	914,204	561,090
Accrued expenses	2,953,648	1,944,431
Other current liabilities	621,572	263,392
Total current liabilities	4,489,424	2,768,913
Other non-current liabilities	373,967	326,282
Total liabilities	4,863,391	3,095,195
Commitments and Contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 11,912,731 and 10,095,176 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively	1,192	1,010
Additional paid-in capital	103,400,598	94,619,818
Accumulated deficit	(92,898,278)	(76,250,512)
Total stockholders’ equity	10,503,512	18,370,316
Total liabilities and stockholders’ equity	$ 15,366,903	$ 21,465,511